Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

15.02.2021

2 AIDS
2 AIDS Res Hum Retroviruses
1 Am J Epidemiol
1 Cell
3 Clin Infect Dis
3 J Acquir Immune Defic Syndr
1 J Clin Invest
1 J Immunol
5 J Infect Dis
1 J Med Virol
4 J Virol
1 Nature
1 PLoS Comput Biol
1 PLoS Med
18 PLoS One
2 PLoS Pathog
1 Science
1 Virology



    AIDS

  1. JAMES CW, Szabo S, Kahal D, Goldstein ND, et al
    The effect of multivitamins and polyvalent cations on virologic suppression with integrase strand transfer inhibitors.
    AIDS. 2020;34:487-489.
    >> Share

  2. VILLINGER F
    In-vivo use of SIVmac239 with a reversing stop codon in the SIV nef gene.
    AIDS. 2020;34:487.
    >> Share


    AIDS Res Hum Retroviruses

  3. YORK L, Fisher JM, Malladi L, August JA, et al
    Antiretroviral Laboratory Monitoring and Implications for HIV Clinical Care in the Era of COVID-19 and Beyond.
    AIDS Res Hum Retroviruses. 2021 Feb 10. doi: 10.1089/AID.2020.0263.
    >> Share

  4. HU M, Valicherla GR, Zhou T, Hillier SL, et al
    Expression, activity, and regulation of phosphorylating enzymes in tissues and cells relevant to HIV-1 sexual transmission.
    AIDS Res Hum Retroviruses. 2021 Feb 10. doi: 10.1089/AID.2020.0250.
    >> Share


    Am J Epidemiol

  5. KERSCHBERGER B, Boulle A, Kuwengwa R, Ciglenecki I, et al
    The Impact of Same-Day Antiretroviral Therapy Initiation under the WHO Treat-All Policy.
    Am J Epidemiol. 2021 Feb 12. pii: 6133987. doi: 10.1093.
    >> Share


    Cell

  6. ZILA V, Margiotta E, Turonova B, Muller TG, et al
    Cone-shaped HIV-1 capsids are transported through intact nuclear pores.
    Cell. 2021 Feb 4. pii: S0092-8674(21)00068-4. doi: 10.1016/j.cell.2021.
    >> Share


    Clin Infect Dis

  7. DORFMAN JR, Balla SR, Pathirana J, Groome MJ, et al
    In utero human cytomegalovirus infection is associated with increased levels of putatively protective maternal antibodies in nonprimary infection: evidence for boosting but not protection.
    Clin Infect Dis. 2021 Feb 9. pii: 6131727. doi: 10.1093.
    >> Share

  8. KENDALL MA, Lalloo U, Fletcher CV, Wu X, et al
    Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin vs. Lopinavir/Ritonavir + Daily Rifabutin for Treatment of HIV-TB Coinfection.
    Clin Infect Dis. 2021 Feb 9. pii: 6131728. doi: 10.1093.
    >> Share

  9. HILEMAN CO, Azzam S, Schlatzer D, Wu K, et al
    Plasma Citrate and Succinate Are Associated with Neurocognitive Impairment in Older People with HIV.
    Clin Infect Dis. 2021 Feb 10. pii: 6132094. doi: 10.1093.
    >> Share


    J Acquir Immune Defic Syndr


  10. Bacterial Vaginosis and Risk of HIV Infection in the Context of CD101 Gene Variation: Erratum.
    J Acquir Immune Defic Syndr. 2021;86:387.
    >> Share

  11. PLUZNIK JA, Nijhawan AE, Spaulding AC
    Does Anything Work? Improving HIV Care Engagement for Individuals Transitioning out of Correctional Settings.
    J Acquir Immune Defic Syndr. 2021;86:286-287.
    >> Share

  12. FARAHANI M, Radin E, Saito S, Sachathep K, et al
    Population Viral Load, Viremia and Recent HIV-1 Infections: Findings from Population-based HIV Impact Assessments (PHIAs) in Zimbabwe, Malawi, and Zambia.
    J Acquir Immune Defic Syndr. 2021 Feb 5. pii: 00126334-900000000-95947.
    >> Share


    J Clin Invest

  13. TEBAS P, Jadlowsky JK, Shaw PA, Tian L, et al
    CCR5-edited CD4 T cells augment HIV-specific immunity to enable post rebound control of HIV replication.
    J Clin Invest. 2021 Feb 11. pii: 144486. doi: 10.1172/JCI144486.
    >> Share


    J Immunol

  14. TURMAN JM, Cheplowitz AM, Tiwari C, Thomas T, et al
    Accelerated Clearance and Degradation of Cell-Free HIV by Neutralizing Antibodies Occurs via FcgammaRIIb on Liver Sinusoidal Endothelial Cells by Endocytosis.
    J Immunol. 2021 Feb 10. pii: jimmunol.2000772. doi: 10.4049/jimmunol.2000772.
    >> Share


    J Infect Dis

  15. ELLSWORTH GB, Wilkin TJ
    Another Call for Widespread Human Papillomavirus Vaccination.
    J Infect Dis. 2019 Oct 5. pii: 5581839. doi: 10.1093.
    >> Share

  16. BARROSO LF
    The Natural History of Anal Dysplasia: Unwrapping the Riddle to Find an Enigma.
    J Infect Dis. 2020;222:7-8.
    >> Share

  17. RON R, Cabello A, Gosalbes MJ, Sanchez-Conde M, et al
    Exploiting the Microbiota for the Diagnosis of Anal Precancerous Lesions in Men Who Have Sex With Men.
    J Infect Dis. 2021 Feb 5. pii: 6129308. doi: 10.1093.
    >> Share

  18. WALL KM, Karita E, Nyombayire J, Ingabire R, et al
    Genital abnormalities, hormonal contraception, and HIV transmission risk in Rwandan serodifferent couples.
    J Infect Dis. 2021 Feb 9. pii: 6131738. doi: 10.1093.
    >> Share

  19. CHITNENI P, Matthews LT
    The Other U=U. Untested and Untreated genital tract inflammation in people living with and exposed to HIV.
    J Infect Dis. 2021 Feb 10. pii: 6131968. doi: 10.1093.
    >> Share


    J Med Virol

  20. ROJAS-BOLIVAR D, Intimayta-Escalante C, Cardenas-Jara A, Jandarov R, et al
    COVID-19 case fatality rate and tuberculosis in a metropolitan setting.
    J Med Virol. 2021 Feb 11. doi: 10.1002/jmv.26868.
    >> Share


    J Virol

  21. MAVIGNER M, Liao LE, Brooks AD, Ke R, et al
    CD8 lymphocyte depletion enhances the latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed SIV-infected rhesus macaques.
    J Virol. 2021 Feb 10. pii: JVI.01429-20. doi: 10.1128/JVI.01429.
    >> Share

  22. LEVY Y, Lacabaratz C, Lhomme E, Wiedemann A, et al
    A randomized placebo-controlled efficacy study of a prime boost therapeutic vaccination strategy in HIV-1 infected individuals: VRI02 ANRS 149 LIGHT Phase II trial.
    J Virol. 2021 Feb 10. pii: JVI.02165-20. doi: 10.1128/JVI.02165.
    >> Share

  23. ZIANI W, Bauer A, Lu H, Wang X, et al
    Immune responses and viral persistence in SHIV.C.CH848-infected rhesus macaques.
    J Virol. 2021 Feb 10. pii: JVI.02198-20. doi: 10.1128/JVI.02198.
    >> Share

  24. SANDSTROM TS, Ranganath N, Burke Schinkel SC, Salahuddin S, et al
    HIV-infected macrophages are infected and killed by the interferon-sensitive Rhabdovirus, MG1.
    J Virol. 2021 Feb 10. pii: JVI.01953-20. doi: 10.1128/JVI.01953.
    >> Share


    Nature

  25. WAHL A, Gralinski LE, Johnson CE, Yao W, et al
    SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.
    Nature. 2021 Feb 9. pii: 10.1038/s41586-021-03312.
    >> Share


    PLoS Comput Biol

  26. FISCON G, Conte F, Farina L, Paci P, et al
    SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
    PLoS Comput Biol. 2021;17:e1008686.
    >> Share


    PLoS Med

  27. KOSS CA, Havlir DV, Ayieko J, Kwarisiima D, et al
    HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
    PLoS Med. 2021;18:e1003492.
    >> Share


    PLoS One

  28. HOULE B, Kabudula CW, Stein A, Gareta D, et al
    Linking the timing of a mother's and child's death: Comparative evidence from two rural South African population-based surveillance studies, 2000-2015.
    PLoS One. 2021;16:e0246671.
    >> Share

  29. MWENDA N, Nduati R, Kosgei M, Kerich G, et al
    Skewed logit model for analyzing correlated infant morbidity data.
    PLoS One. 2021;16:e0246269.
    >> Share

  30. SOEROTO AY, Pratiwi C, Santoso P, Lestari BW, et al
    Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study.
    PLoS One. 2021;16:e0246284.
    >> Share

  31. INIESTA C, Coll P, Barbera MJ, Garcia Deltoro M, et al
    Implementation of pre-exposure prophylaxis programme in Spain. Feasibility of four different delivery models.
    PLoS One. 2021;16:e0246129.
    >> Share

  32. STRANIX-CHIBANDA L, Tierney C, Sebikari D, Aizire J, et al
    Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial.
    PLoS One. 2021;16:e0246272.
    >> Share

  33. MWAKA ES, Munabi IG, Castelnuovo B, Kaimal A, et al
    Low bone mass in people living with HIV on long-term anti-retroviral therapy: A single center study in Uganda.
    PLoS One. 2021;16:e0246389.
    >> Share

  34. AGUTU CA, Oduor TH, Kombo BK, Mugo PM, et al
    High patient acceptability but low coverage of provider-initiated HIV testing among adult outpatients with symptoms of acute infectious illness in coastal Kenya.
    PLoS One. 2021;16:e0246444.
    >> Share

  35. NGUYEN KA, Peer N, Kengne AP
    Associations of gamma-glutamyl transferase with cardio-metabolic diseases in people living with HIV infection in South Africa.
    PLoS One. 2021;16:e0246131.
    >> Share

  36. JITTIKOON J, Sangroongruangsri S, Thavorncharoensap M, Chitpim N, et al
    Economic impact of medical genetic testing on clinical applications in Thailand.
    PLoS One. 2020;15:e0243934.
    >> Share

  37. HEID-PICARD B, Cochand-Priollet B, Rozenberg F, Giang-Phang D, et al
    Ambulatory anal self-sampling in MSM living with HIV, an acceptable and reliable screening method.
    PLoS One. 2021;16:e0246338.
    >> Share

  38. POLANKA BM, Kundu S, So-Armah KA, Freiberg MS, et al
    Insomnia symptoms and biomarkers of monocyte activation, systemic inflammation, and coagulation in HIV: Veterans Aging Cohort Study.
    PLoS One. 2021;16:e0246073.
    >> Share

  39. BANERDT JK, Mateyo K, Wang L, Lindsell CJ, et al
    Delirium as a predictor of mortality and disability among hospitalized patients in Zambia.
    PLoS One. 2021;16:e0246330.
    >> Share

  40. FIX GM, Dryden EM, Boudreau J, Kressin NR, et al
    The temporal nature of social context: Insights from the daily lives of patients with HIV.
    PLoS One. 2021;16:e0246534.
    >> Share

  41. MAPANGA W, Norris SA, Chen WC, Blanchard C, et al
    Consensus study on the health system and patient-related barriers for lung cancer management in South Africa.
    PLoS One. 2021;16:e0246716.
    >> Share

  42. LIMA VD, Wang L, Sereda P, McLinden T, et al
    Estimation of time of HIV seroconversion using a modified CD4 depletion model.
    PLoS One. 2021;16:e0246135.
    >> Share

  43. LOPEZ-VARELA E, Augusto O, Fuente-Soro L, Sacoor C, et al
    Quantifying the gender gap in the HIV care cascade in southern Mozambique: We are missing the men.
    PLoS One. 2021;16:e0245461.
    >> Share

  44. PUTCHAROEN O, Wacharapluesadee S, Chia WN, Paitoonpong L, et al
    Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand.
    PLoS One. 2021;16:e0246864.
    >> Share

  45. NYABUTI MN, Petersen ML, Bukusi EA, Kamya MR, et al
    Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya.
    PLoS One. 2021;16:e0243167.
    >> Share


    PLoS Pathog

  46. GAO Y, He S, Tian W, Li D, et al
    First complete-genome documentation of HIV-1 intersubtype superinfection with transmissions of diverse recombinants over time to five recipients.
    PLoS Pathog. 2021;17:e1009258.
    >> Share

  47. CHARLES TP, Burton SL, Arunachalam PS, Cottrell CA, et al
    The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection.
    PLoS Pathog. 2021;17:e1009257.
    >> Share


    Science

  48. WANG Q, Gao H, Clark KM, Mugisha CS, et al
    CARD8 is an inflammasome sensor for HIV-1 protease activity.
    Science. 2021 Feb 4. pii: science.abe1707. doi: 10.1126/science.abe1707.
    >> Share


    Virology

  49. MONDAL S, Karmakar A, Mallick T, Begum NA, et al
    Exploring the efficacy of naturally occurring biflavone based antioxidants towards the inhibition of the SARS-CoV-2 spike glycoprotein mediated membrane fusion.
    Virology. 2021;556:133-139.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016